|
| 1 |
Comprehensive clinical characterization of patients with BRCA1: c.5017_5019del germline variant
Yoon Ju Bang, Won Kyung Kwon, Jong-Won Kim, Jeong Eon Lee, Boo Yeon Jung, Mina Kim, Jisun Kim, Jeongshin An, Seung Pil Jung, Hong-Kyu Kim, Zisun Kim, Hyun Jo Youn, Jai Min Ryu, Sung-Won Kim,
|
|
| 2 |
Cost-effective BRCA Testing in Advanced Ovarian Cancer
Myungshin Kim
Ann Lab Med.2023;43(1):3-4. Published online 2022 September 1
DOI: http://dx.doi.org/10.3343/alm.2023.43.1.3
|
|
| 3 |
Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
Se Ik Kim, Hyunji Lim, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Maria Lee
Cancer Res Treat.2023;55(1):245-257. Published online 2022 July 19
DOI: http://dx.doi.org/10.4143/crt.2022.232
|
|
| 4 |
Founder BRCA1 mutations in Nepalese population
Anurag Mehta, Himanshi Diwan, Garima Gupta, Shrinidhi Nathany, Shalini Agnihotri, Surender Dhanda
|
|
| 5 |
Reclassification of Five BRCA1/2 Variants with Unknown Significance Using Complex Functional Study
Anikó Bozsik, János Papp, Vince Kornél Grolmusz, Attila Patócs, Edit Oláh, Henriett Butz
Cancer Res Treat.2022;54(4):970-984. Published online 2022 February 8
DOI: http://dx.doi.org/10.4143/crt.2021.1078
|
|
| 6 |
Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients
Yoon Ju Bang, Won Kyung Kwon, Seok Jin Nam, Seok Won Kim, Byung-Joo Chae, Se Kyung Lee, Jai Min Ryu, Jong-Won Kim, Jonghan Yu, Jeong Eon Lee
Cancer Res Treat.2022;54(3):827-833. Published online 2021 October 13
DOI: http://dx.doi.org/10.4143/crt.2021.791
|
|
| 7 |
Disparities between Uptake of Germline BRCA1/2 Gene Tests and Implementation of Post-test Management Strategies in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Young Min Hur, Jaehee Mun, Mi-Kyung Kim, Maria Lee, Yun Hwan Kim, Seung-Cheol Kim
|
|
| 8 |
Talazoparib versus Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA Trial
Kyung-Hun Lee, Joohyuk Sohn, Annabel Goodwin, Tiziana Usari, Silvana Lanzalone, Seock-Ah Im, Sung-Bae Kim
Cancer Res Treat.2021;53(4):1084-1095. Published online 2021 March 24
DOI: http://dx.doi.org/10.4143/crt.2020.1381
|
|
| 9 |
Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
Roshni D. Kalachand, Ciaran O’Riain, Sinead Toomey, Aoife Carr, Kirsten M. Timms, Sharon O’Toole, Stephen Madden, Mark Bates, John J. O’Leary, Noreen Gleeson, Dearbhaile O’Donnell, Liam Grogan, Oscar Breathnach, Angela Farrelly, Britta Stordal, Bryan T. Hennessy
Obstet Gynecol Sci.2020;63(5):643-654. Published online 2020 September 2
DOI: http://dx.doi.org/10.5468/ogs.20033
|
|
| 10 |
Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song
Cancer Res Treat.2020;52(4):1229-1241. Published online 2020 July 27
DOI: http://dx.doi.org/10.4143/crt.2020.557
|
|
| 11 |
Clinicopathological characteristics of BRCA-associated breast cancer in Asian patients
Eun-Kyu Kim, So Yeon Park, Sung-Won Kim
|
|
| 12 |
Clinicopathological Features of Patients with the BRCA1 c.5339T>C (p.Leu1780Pro) Variant
Hyung Seok Park, Jai Min Ryu, Ji Soo Park, Seock-Ah Im, So-Youn Jung, Eun-Kyu Kim, Woo-Chan Park, Jun Won Min, Jeeyeon Lee, Ji Young You, Jeong Eon Lee, Sung-Won Kim
Cancer Res Treat.2020;52(3):680-688. Published online 2020 January 28
DOI: http://dx.doi.org/10.4143/crt.2019.351
|
|
| 13 |
BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies
Anbok Lee, Byung-In Moon, Tae Hyun Kim
Ann Lab Med.2020;40(2):114-121. Published online 2019 October 23
DOI: http://dx.doi.org/10.3343/alm.2020.40.2.114
|
|
| 14 |
Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome
Jaeeun Yoo, Gun Dong Lee, Jee Hae Kim, Seung Nam Lee, Hyojin Chae, Eunhee Han, Yonggoo Kim, Myungshin Kim
Ann Lab Med.2020;40(2):148-154. Published online 2019 October 23
DOI: http://dx.doi.org/10.3343/alm.2020.40.2.148
|
|
| 15 |
Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea
Jun Hyeong Seo, Soo Young Jeong, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi
|
|
| 16 |
Contralateral Breast Cancer and Ipsilateral Breast Tumor Recurrence in BRCA1/2 Carriers and Non-Carriers at High-Risk of Hereditary Breast Cancer
Kyung-Hwak Yoon, Sumin Chae, Eunyoung Kang, Hee-Chul Shin, Jee Hyun Kim, In Ah Kim, So Yeon Park, Sung-Won Kim, Eun-Kyu Kim
J Breast Cancer.2019;22(4):587-598. Published online 2019 September 30
DOI: http://dx.doi.org/10.4048/jbc.2019.22.e47
|
|
| 17 |
Trends in contralateral prophylactic mastectomy rate according to clinicopathologic and socioeconomic status
Ho Jong Jeon, Hyung Seok Park, Ji Soo Park, Eun Ji Nam, Seung-Tae Lee, Jeongwoo Han
|
|
| 18 |
An optimized BRCA1/2 next-generation sequencing for different clinical sample types
Yoonjung Kim, Chi-Heum Cho, Jung-Sook Ha, Do-Hoon Kim, Sun Young Kwon, Seoung Chul Oh, Kyung-A Lee
|
|
| 19 |
Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group
Chyong-Huey Lai, Elizabeth Vallikad, Hao Lin, Lan-Yan Yang, Shih-Ming Jung, Hsueh-Erh Liu, Yu-Che Ou, Hung-Hsueh Chou, Cheng-Tao Lin, Huei-Jean Huang, Kuan-Gen Huang, Jiantai Qiu, Yao-Ching Hung, Tzu-I Wu, Wei-Yang Chang, Kien-Thiam Tan, Chiao-Yun Lin, Angel Chao, Chee-Jen Chang
|
|
| 20 |
Novel Germline Mutations of BRCA1 and BRCA2 in Korean Familial Breast Cancer Patients
Hee Nam Kim, Min-Ho Shin, Ran Lee, Min-Ho Park, Sun-Seog Kweon
|
|
